New evidence shows that GLP-1based therapies not only lower glucose levels and aid in weight loss but also reduce inflammation in the heart, kidneys, liver, and brain, revealing a broader therapeutic potential beyond metabolism
Zepbound KwikPen is the only dual-action GLP-1/GIP medication approved for weight management, with the highest average weight loss in clinical trials (22%)
Earlier this month, FORM, a virtual obesity medicine clinic, officially launched FORMfit, a new program helping employers expand access to clinical obesity care while managing costs.
d,g , Negative ( d ) and positive ( g ) ion ESI-MS spectrum of the At LDOX oxidation product from 3,4- cis -leucocyanidin ( 6 )
In the meantime, Retatrutide is available in Canada as a research peptide through specialized suppliers